February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
December 19, 2018 | Press Releases GHO Capital Acquires Validant, a Leading Quality, Compliance and Regulatory Affairs Consulting Firm for Healthcare Companies Carla Nieser 2 Minute Read
December 16, 2018 | Compliance EU MDR/IVDR Compliance: A Road Map for Success Stephanie Colotti Senior Partner, Validant 1 Minute Read
July 16, 2018 | Regulatory Utilize Risk Management Files for a Competitive Advantage John McShane Managing Partner, Validant 2 Minute Read
March 8, 2018 | Quality Outsourcing to a Contract Manufacturer? Don’t Forget the Quality Agreement Stephanie Colotti Senior Partner, Validant 2 Minute Read
February 15, 2018 | Compliance Closing the Gaps: Next Steps in EU MDR Compliance Brian Burns CEO, Validant 3 Minute Read
February 5, 2018 | Compliance Gap Assessments: A Vital First Step to Comply with New EU Medical Device Regulations Brian Burns CEO, Validant 2 Minute Read
January 10, 2018 | Regulatory Virtualization Poses Risks to Data Integrity in Clinical Trials Stephanie Colotti Senior Partner, Validant 3 Minute Read